OPTX · XBRL financial data
Syntec Optics Holdings financial statements, every fiscal year
The same tables from 7 filings, lined up. Matched by XBRL tag: renamed lines keep their history.
How these numbers work
- Every number comes from the company's XBRL financial data filed with the SEC, and each one links to its filing.
- Lines are matched by XBRL tag, so a line renamed between filings keeps its history.
- * marks a quarter worked out from the filing totals: the 10-K year minus the first three quarters, or a year-to-date total minus the earlier one. Fourth-quarter earnings per share is fourth-quarter net income over the fourth-quarter weighted shares.
- 0 means a filing states zero; a dash (—) means no filing states that number.
- “year only” means the 10-K gives the full year but not the quarters needed to work out the fourth. A worked-out quarter of revenue, cost of revenue or operating cash flow more than twice the company's largest quarter of the two years before is shown this way too.
- Gross profit is shown as the company reports it; a worked-out quarter must equal revenue less cost of revenue for that quarter, or it is a dash.
- Operating income can be above gross profit when the company books other operating income between the two, shown on its own line.
- Shares outstanding come from each filing's cover page, as of the date printed there.
- Quarters are fiscal: Q2 FY27 is the second quarter of the company's fiscal 2027.
Income statement
CSVFiscal years (OPTX's year ends in late December)
| In thousands of dollars | Dec 31, 2021 | Dec 31, 2022 | Dec 31, 2023 | Dec 31, 2024 | Dec 31, 2025 |
|---|---|---|---|---|---|
| Revenue from contracts with customers | — | 27,839 | 29,441 | 28,450 | 28,084 |
| Cost of revenue | — | 21,713 | 21,520 | 22,748 | 21,554 |
| Gross profit | — | 6,126 | 7,921 | 5,702 | 6,530 |
| Research and development | — | — | — | 1,000 | 600 |
| General and administrative | — | 6,654 | 6,380 | 8,279 | 7,047 |
| Total operating expenses | — | 788 | — | — | — |
| Operating income (loss) | — | (788) | 1,541 | (2,576) | (518) |
| Other income (expense) | — | — | — | 347 | (40) |
| Income tax expense (benefit) | — | 446 | (719) | (515) | 440 |
| Net income (loss) | — | 848 | 1,976 | (2,480) | (1,793) |
| Earnings per share, basic USD per share | — | (0.01) | 0.06 | (0.07) | (0.05) |
| Earnings per share, diluted USD per share | — | (0.01) | 0.06 | (0.07) | (0.05) |
| Weighted average shares, basic thousands of shares | — | 31,600 | 32,367 | 36,688 | 36,920 |
| Weighted average shares, diluted thousands of shares | — | 31,600 | 32,367 | 36,688 | 36,920 |
Balance sheet
CSVFiscal years (OPTX's year ends in late December)
| In thousands of dollars | Dec 31, 2021 | Dec 31, 2022 | Dec 31, 2023 | Dec 31, 2024 | Dec 31, 2025 |
|---|---|---|---|---|---|
| Cash and cash equivalents | 495 | 118 | 2,158 | 599 | 359 |
| Marketable securities, non-current | 146,627 | 14,011 | — | — | — |
| Accounts receivable | — | 3,895 | 4,506 | 3,200 | 3,700 |
| Inventory | — | 3,626 | 5,834 | 6,953 | 7,885 |
| Prepaid and other current assets | — | — | — | — | 656 |
| Total current assets | 667 | 261 | 15,152 | 13,898 | 15,141 |
| Property and equipment, net | — | 11,625 | 11,101 | 11,669 | 9,173 |
| Total assets | 147,428 | 14,272 | 26,548 | 26,006 | 24,314 |
| Accounts payable | 204 | 117 | 3,042 | 2,706 | 2,692 |
| Accrued liabilities | — | 540 | 1,071 | 815 | 683 |
| Current portion of long-term debt | — | 1,625 | 363 | 468 | 500 |
| Total current liabilities | 204 | 117 | 11,384 | 10,573 | 11,229 |
| Long-term debt | — | 1,914 | 2,025 | 2,615 | 2,129 |
| Lease liability, non-current | — | 50 | — | — | — |
| Total liabilities | 5,235 | 617 | 13,484 | 14,972 | 14,773 |
| Retained earnings (accumulated deficit) | (4,433) | (266) | 11,133 | 8,653 | 6,860 |
| Total stockholders' equity | (4,432) | (265) | 13,064 | 11,034 | 9,541 |
| Total liabilities and equity | 147,428 | 14,272 | 26,548 | 26,006 | 24,314 |
| Common shares outstanding (cover page) thousands of shares | — | 31,600 | 36,688 | 36,920 | 36,994 |
Cash flows
CSVFiscal years (OPTX's year ends in late December)
| In thousands of dollars | Dec 31, 2021 | Dec 31, 2022 | Dec 31, 2023 | Dec 31, 2024 | Dec 31, 2025 |
|---|---|---|---|---|---|
| Net income (loss) | — | 848 | 1,976 | (2,480) | (1,793) |
| Stock-based compensation | — | — | — | 450 | 300 |
| Depreciation and amortization | — | 3,141 | 2,769 | 2,766 | 2,613 |
| Net cash from operating activities | — | (644) | 2,792 | (943) | 673 |
| Purchases of property and equipment | — | 1,242 | 1,921 | 1,240 | 644 |
| Net cash from investing activities | — | (685) | (1,921) | (931) | (644) |
| Proceeds from issuing equity | 143,750 | — | — | — | — |
| Net cash from financing activities | — | 267 | 761 | 314 | (268) |
| Net change in cash | — | (377) | 1,632 | (1,559) | (240) |
Compare with peers
SIC 3827 and related industry codes, similar size. Each row is the latest quarter reported.
How peers are chosen
- SIC 3827 and related industry codes with public float (or, where float is missing, quarterly revenue) between 0.2x and 5x the company's.
- Each row is the latest quarter the company has reported, named in the Quarter column; when that filing is a 10-K, it is the fourth quarter, never the full year.
- Runway shows only for companies burning cash with under $10B of public float.
- * marks a quarter worked out from the filing totals: for a 10-K, the year less the first three quarters; for a 10-Q, the year-to-date total less the earlier one.
- A cell reading “not reported” means the filings give no figure for that quarter alone.
| Company | Cash ($K) | Revenue, quarter ($K) | Operating cash flow, quarter ($K) | Shares outstanding | Runway | Quarter |
|---|---|---|---|---|---|---|
| Syntec Optics Holdings | 14,047 | 8,274 | (299)* | 40.3M | 47.0 quarters | 10-QJun 30, 2026 |
| Radnostix | 1,196 | 2,672 | (614)* | 529.2M | 2.0 quarters | 10-QJun 30, 2026 |
| Electro Sensors | 10,756 | not reported | 68 | 3.5M | — | 10-QMar 31, 2026 |
| Bionano Genomics | 3,730 | 8,171 | (4,670)* | 11.8M | 2.1 quarters | 10-QJun 30, 2026 |
| ASTROTECH | 8,387 | not reported | (2,288)* | 2.0M | 5.0 quarters | 10-KJun 30, 2026 |
| Focus Universal | 1,600 | 675 | (741)* | 702,745 | 2.2 quarters | 10-QJun 30, 2026 |
| Precipio | 3,075 | 7,021 | 660* | 1.8M | — | 10-QJun 30, 2026 |
| Scientific Industries | 617 | 1,470 | (904)* | 11.9M | 5.0 quarters | 10-QJun 30, 2026 |
| Harvard Bioscience | 6,503 | 22,727 | 325* | 4.6M | — | 10-QJun 30, 2026 |
Not investment advice. Not affiliated with the U.S. SEC.